Seobu T&D Co., Ltd. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022
August 12, 2022 at 07:32 am
Share
Seobu T&D Co., Ltd. reported earnings results for the second quarter and six months ended June 30, 2022. For the second quarter, the company reported sales was KRW 33,779.18 million compared to KRW 23,325.29 million a year ago. Net loss was KRW 7,801.54 million compared to KRW 10,089.39 million a year ago. Basic loss per share from continuing operations was KRW 131.3725 compared to KRW 170.1269 a year ago. Basic loss per share was KRW 131.3725 compared to KRW 173.5294 a year ago.
For the six months, sales was KRW 60,537.66 million compared to KRW 42,508.95 million a year ago. Net loss was KRW 13,973.44 million compared to KRW 18,634.9 million a year ago. Basic loss per share from continuing operations was KRW 235.2941 compared to KRW 313.7255 a year ago. Diluted loss per share from continuing operations was KRW 235.2941. Basic loss per share was KRW 235.2941 compared to KRW 313.7255 a year ago.
Seobu T&D Co Ltd is a Korea-based company principally engaged in the stem cell business. The Company operates its business through five segments. The Tourist Hotel segment operates Hotelplexes. The Shopping Mall Operation segment operates the shopping malls. The Logistics Facility Operation segment provides logistics facilities such as warehouses, cargo dumps, office buildings, and vehicle parking facilities. The Petroleum Sales segment operates the petroleum sales business, such as oil and non-oil products. The Rental and Other Business segment operates rental businesses.